Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Shanghai Green Valley

- PMLiVE

Merck Serono signs diabetes partnership with BMS in China

Will co-promote Glucophage (metformin) formulations

China: Engagement strategies

As China grows apace, digital is increasingly being used to engage both customers and patients

- PMLiVE

Merck taps Luminex for Alzheimer’s biomarker

Licenses companion diagnostic to use in its clinical trials

- PMLiVE

ACC and Boehringer develop CME programme in China

Will focus on stroke prevention in atrial fibrillation

- PMLiVE

Pharma CEOs team up to tackle Alzheimer’s

Call for Global Alzheimer’s Action Plan to prevent and treat neurological condition by 2025

- PMLiVE

WuXi Pharmatech and OMT expand antibodies agreement

Enables Chinese CRO to increase its service offering

- PMLiVE

Biosimilars in China

Tipping the balance: risks and opportunities in biosimilars

- PMLiVE

Takeda launches new business in China

Will serve as hub for importing medicines from across the world

- PMLiVE

Lilly gets go-ahead for Alzheimer’s diagnostic in EU

Amyvid can detect amyloid plaques – a hallmark of the condition

WuXi and PRA form Chinese joint venture

Combine to form new China-focused independentCRO

- PMLiVE

Lilly pays $29m to settle foreign bribery charges

US Securities and Exchange Commission charges centre on activities in Russia, China, Brazil and Poland

- PMLiVE

Lilly plans another trial for Alzheimer’s hope solanezumab

Presses on with another late-stage study for the drug

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links